DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update
DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis